TY - JOUR AU - Whelton, P. K. AU - Carey, R. M. AU - Aronow, W. S. AU - Casey, D. E. AU - Collins, K. J. AU - Dennison Himmelfarb, C. PY - 2018 DA - 2018// TI - 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines JO - Hypertension VL - 71 UR - https://doi.org/10.1161/HYP.0000000000000065 DO - 10.1161/HYP.0000000000000065 ID - Whelton2018 ER - TY - JOUR AU - Muntner, P. AU - Carey, R. M. AU - Gidding, S. AU - Jones, D. W. AU - Taler, S. J. AU - Wright, J. T. PY - 2018 DA - 2018// TI - Potential U.S. population impact of the 2017 ACC/AHA high blood pressure guideline JO - J Am Coll Cardiol VL - 71 UR - https://doi.org/10.1016/j.jacc.2017.10.073 DO - 10.1016/j.jacc.2017.10.073 ID - Muntner2018 ER - TY - JOUR AU - Egan, B. M. AU - Li, J. AU - Hutchison, F. N. AU - Ferdinand, K. C. PY - 2014 DA - 2014// TI - Hypertension in the United States, 1999 to 2012: progress toward healthy people 2020 goals JO - Circulation VL - 130 UR - https://doi.org/10.1161/CIRCULATIONAHA.114.010676 DO - 10.1161/CIRCULATIONAHA.114.010676 ID - Egan2014 ER - TY - JOUR AU - Vos, T. AU - Flaxman, A. D. AU - Naghavi, M. AU - Lozano, R. AU - Michaud, C. AU - Ezzati, M. PY - 2012 DA - 2012// TI - Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010 JO - Lancet VL - 380 UR - https://doi.org/10.1016/s0140-6736(12)61729-2 DO - 10.1016/s0140-6736(12)61729-2 ID - Vos2012 ER - TY - JOUR AU - Zaman, M. A. AU - Oparil, S. AU - Calhoun, D. A. PY - 2002 DA - 2002// TI - Drugs targeting the renin-angiotensin-aldosterone system JO - Nat Rev Drug Discov VL - 1 UR - https://doi.org/10.1038/nrd873 DO - 10.1038/nrd873 ID - Zaman2002 ER - TY - JOUR AU - Skeggs, L. T. AU - Kahn, J. R. AU - Lentz, K. AU - Shumway, N. P. PY - 1957 DA - 1957// TI - The preparation, purification, and amino acid sequence of a polypeptide renin substrate JO - J Exp Med VL - 106 UR - https://doi.org/10.1084/jem.106.3.439 DO - 10.1084/jem.106.3.439 ID - Skeggs1957 ER - TY - JOUR AU - rao, M. S. PY - 2010 DA - 2010// TI - Inhibition of the renin Angiotensin Aldosterone System: focus on Aliskiren JO - JAPI VL - 58 ID - rao2010 ER - TY - JOUR AU - Musini, V. M. AU - Lawrence, K. A. AU - Fortin, P. M. AU - Bassett, K. AU - Wright, J. M. PY - 2017 DA - 2017// TI - Blood pressure lowering efficacy of renin inhibitors for primary hypertension JO - Cochrane Database Syst Rev VL - 4 UR - https://doi.org/10.1002/14651858.CD007066.pub3 DO - 10.1002/14651858.CD007066.pub3 ID - Musini2017 ER - TY - JOUR AU - Makani, H. AU - Bangalore, S. AU - Desouza, K. A. AU - Shah, A. AU - Messerli, F. H. PY - 2013 DA - 2013// TI - Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials JO - Bmj VL - 346 UR - https://doi.org/10.1136/bmj.f360 DO - 10.1136/bmj.f360 ID - Makani2013 ER - TY - JOUR AU - Nijst, P. AU - Verbrugge, F. H. AU - Martens, P. AU - Bertrand, P. B. AU - Dupont, M. AU - Francis, G. S. PY - 2017 DA - 2017// TI - Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy JO - J Renin-Angiotensin-Aldosterone Syst VL - 18 UR - https://doi.org/10.1177/1470320317729919 DO - 10.1177/1470320317729919 ID - Nijst2017 ER - TY - JOUR AU - Braam, B. AU - Koomans, H. PY - 1996 DA - 1996// TI - Renal responses to antagonism of the renin-angiotensin system JO - Curr Opin Nephrol Hypertens VL - 5 UR - https://doi.org/10.1097/00041552-199601000-00015 DO - 10.1097/00041552-199601000-00015 ID - Braam1996 ER - TY - JOUR AU - Riley, R. D. AU - Higgins, J. P. T. AU - Deeks, J. J. PY - 2011 DA - 2011// TI - Interpretation of random effects meta-analyses JO - BMJ VL - 342 UR - https://doi.org/10.1136/bmj.d549 DO - 10.1136/bmj.d549 ID - Riley2011 ER - TY - JOUR AU - JPT, H. AU - Thompson, S. G. AU - JPT, H. PY - 2002 DA - 2002// TI - Thompson SGQuantifying heterogeneity in a meta-analysis JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1186 DO - 10.1002/sim.1186 ID - JPT2002 ER - TY - JOUR AU - Shea, B. J. AU - Reeves, B. C. AU - Wells, G. AU - Thuku, M. AU - Hamel, C. AU - Moran, J. PY - 2017 DA - 2017// TI - AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both JO - BMJ VL - 358 UR - https://doi.org/10.1136/bmj.j4008 DO - 10.1136/bmj.j4008 ID - Shea2017 ER - TY - JOUR AU - Chen, Y. AU - Meng, L. AU - Shao, H. AU - Yu, F. PY - 2013 DA - 2013// TI - Aliskiren vs. other antihypertensive drugs in the treatment of hypertension: a meta-analysis JO - Hypertens Res VL - 36 UR - https://doi.org/10.1038/hr.2012.185 DO - 10.1038/hr.2012.185 ID - Chen2013 ER - TY - JOUR AU - Gao, D. AU - Ning, N. AU - Niu, X. AU - Wei, J. AU - Sun, P. AU - Hao, G. PY - 2011 DA - 2011// TI - Aliskiren vs. angiotensin receptor blockers in hypertension: meta-analysis of randomized controlled trials JO - Am J Hypertens VL - 24 UR - https://doi.org/10.1038/ajh.2011.3 DO - 10.1038/ajh.2011.3 ID - Gao2011 ER - TY - JOUR AU - Zhenfeng, Z. AU - Huilan, S. AU - Junya, J. AU - Dong, L. AU - Shan, L. PY - 2011 DA - 2011// TI - A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension JO - J Renin-Angiotensin-Aldosterone Syst VL - 12 UR - https://doi.org/10.1177/1470320310381912 DO - 10.1177/1470320310381912 ID - Zhenfeng2011 ER - TY - JOUR AU - Verdecchia, P. AU - Angeli, F. AU - Mazzotta, G. AU - Ambrosio, G. AU - Reboldi, G. PY - 2010 DA - 2010// TI - Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together? JO - Curr Vasc Pharmacol VL - 8 UR - https://doi.org/10.2174/157016110793563924 DO - 10.2174/157016110793563924 ID - Verdecchia2010 ER - TY - JOUR AU - Powers, B. AU - Greene, L. AU - Balfe, L. M. PY - 2011 DA - 2011// TI - Updates on the treatment of essential hypertension: a summary of AHRQ’s comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors JO - J Manag Care Pharm VL - 17 ID - Powers2011 ER - TY - JOUR AU - Stanton, A. V. AU - Gradman, A. H. AU - Schmieder, R. E. AU - Nussberger, J. AU - Sarangapani, R. AU - Prescott, M. F. PY - 2010 DA - 2010// TI - Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials JO - Hypertension VL - 55 UR - https://doi.org/10.1161/hypertensionaha.109.135772 DO - 10.1161/hypertensionaha.109.135772 ID - Stanton2010 ER - TY - STD TI - Luo Y, Chen Q. Efficacy of aliskiren supplementation for heart failure : a meta-analysis of randomized controlled trials. Herz. 2018. https://doi.org/10.1007/s00059-018-4679-1. ID - ref21 ER - TY - JOUR AU - Zhang, J. T. AU - Chen, K. P. AU - Guan, T. AU - Zhang, S. PY - 2015 DA - 2015// TI - Effect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials JO - Drug Des Devel Ther VL - 9 UR - https://doi.org/10.2147/dddt.S75111 DO - 10.2147/dddt.S75111 ID - Zhang2015 ER - TY - JOUR AU - Zheng, S. L. AU - Roddick, A. J. AU - Ayis, S. PY - 2017 DA - 2017// TI - Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: a systematic review and meta-analysis of 13,395 patients JO - Diab Vasc Dis Res VL - 14 UR - https://doi.org/10.1177/1479164117715854 DO - 10.1177/1479164117715854 ID - Zheng2017 ER - TY - JOUR AU - White, W. B. AU - Bresalier, R. AU - Kaplan, A. P. AU - Palmer, B. F. AU - Riddell, R. H. AU - Lesogor, A. PY - 2011 DA - 2011// TI - Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients JO - J Clin Hypertens (Greenwich) VL - 13 UR - https://doi.org/10.1111/j.1751-7176.2011.00438.x DO - 10.1111/j.1751-7176.2011.00438.x ID - White2011 ER - TY - JOUR AU - Louvis, N. AU - Coulson, J. PY - 2018 DA - 2018// TI - Renoprotection by direct renin inhibition: a systematic review and Meta- analysis JO - Curr Vasc Pharmacol VL - 16 UR - https://doi.org/10.2174/1570161115666170502104809 DO - 10.2174/1570161115666170502104809 ID - Louvis2018 ER - TY - JOUR AU - Rizos, E. C. AU - Agouridis, A. P. AU - Elisaf, M. S. PY - 2012 DA - 2012// TI - Aliskiren in patients with diabetes: a systematic review JO - Curr Vasc Pharmacol VL - 10 UR - https://doi.org/10.2174/157016112799305094 DO - 10.2174/157016112799305094 ID - Rizos2012 ER - TY - JOUR AU - Lambers Heerspink, H. J. AU - Perkovic, V. AU - Zeeuw, D. PY - 2009 DA - 2009// TI - Renal and cardio-protective effects of direct renin inhibition: a systematic literature review JO - J Hypertens VL - 27 UR - https://doi.org/10.1097/HJH.0b013e3283310f92 DO - 10.1097/HJH.0b013e3283310f92 ID - Lambers Heerspink2009 ER - TY - JOUR AU - Latini, R. AU - Masson, S. AU - Wong, M. PY - 2006 DA - 2006// TI - Incremental prognostic value of changes in B-type natriuretic peptide in heart failure JO - Am J Med VL - 119 UR - https://doi.org/10.1016/j.amjmed.2005.08.041 DO - 10.1016/j.amjmed.2005.08.041 ID - Latini2006 ER - TY - JOUR AU - Pantzaris, N. D. AU - Karanikolas, E. AU - Tsiotsios, K. AU - Velissaris, D. PY - 2017 DA - 2017// TI - Renin Inhibition with Aliskiren: A Decade of Clinical Experience JO - J Clin Med VL - 6 UR - https://doi.org/10.3390/jcm6060061 DO - 10.3390/jcm6060061 ID - Pantzaris2017 ER - TY - JOUR AU - McMurray, J. J. AU - Krum, H. AU - Abraham, W. T. AU - Dickstein, K. AU - Kober, L. V. AU - Desai, A. S. PY - 2016 DA - 2016// TI - Aliskiren, Enalapril, or Aliskiren and Enalapril in heart failure JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1514859 DO - 10.1056/NEJMoa1514859 ID - McMurray2016 ER - TY - JOUR AU - Parving, H. H. AU - Brenner, B. M. AU - McMurray, J. J. AU - Zeeuw, D. AU - Haffner, S. M. AU - Solomon, S. D. PY - 2012 DA - 2012// TI - Cardiorenal end points in a trial of aliskiren for type 2 diabetes JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1208799 DO - 10.1056/NEJMoa1208799 ID - Parving2012 ER - TY - JOUR AU - Okada, Y. AU - Shibata, S. AU - Fujimoto, N. AU - Best, S. AU - Levine, B. AU - Fu, Q. PY - 2017 DA - 2017// TI - Long-term effects of a renin inhibitor versus a thiazide diuretic on arterial stiffness and left ventricular diastolic function in elderly hypertensive patients JO - Am J Phys Regul Integr Comp Phys VL - 313 UR - https://doi.org/10.1152/ajpregu.00125.2017 DO - 10.1152/ajpregu.00125.2017 ID - Okada2017 ER - TY - BOOK AU - Okada, Y. AU - Shibata, S. AU - Fujimoto, N. AU - Best, S. AU - Levine, B. D. AU - Fu, Q. PY - 2017 DA - 2017// TI - Long-term effects of a renin inhibitor versus a thiazide diuretic on arterial stiffness and left ventricular diastolic function in elderly hypertensive patients UR - https://doi.org/10.1152/ajpregu.00125.2017 DO - 10.1152/ajpregu.00125.2017 ID - Okada2017 ER - TY - JOUR AU - Rashid, H. U. PY - 2010 DA - 2010// TI - Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control JO - Integr Blood Press Control VL - 3 UR - https://doi.org/10.2147/IBPC.S12407 DO - 10.2147/IBPC.S12407 ID - Rashid2010 ER - TY - JOUR AU - Coffman, T. M. AU - Crowley, S. D. PY - 2008 DA - 2008// TI - Kidney in hypertension: Guyton redux JO - Hypertension VL - 51 UR - https://doi.org/10.1161/HYPERTENSIONAHA.105.063636 DO - 10.1161/HYPERTENSIONAHA.105.063636 ID - Coffman2008 ER - TY - JOUR AU - Gheorghiade, M. AU - Böhm, M. AU - Greene, S. AU - Fonarow, G. AU - Lewis, E. AU - Zannad, F. PY - 2013 DA - 2013// TI - Effect of Aliskiren on Postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure the ASTRONAUT randomized trial JO - JAMA VL - 309 UR - https://doi.org/10.1001/jama.2013.1954 DO - 10.1001/jama.2013.1954 ID - Gheorghiade2013 ER - TY - JOUR AU - Makani, H. AU - Bangalore, S. AU - Desouza, K. AU - Shah, A. AU - Fh, M. PY - 2013 DA - 2013// TI - Efficacy and safety of dual blockade of the renin-angiotensin system: Meta-analysis of randomised trials JO - BMJ Br Med J VL - 346 UR - https://doi.org/10.1136/bmj.f360 DO - 10.1136/bmj.f360 ID - Makani2013 ER - TY - CHAP AU - Sanders, G. D. AU - Coeytaux, R. AU - Dolor, R. J. AU - Hasselblad, V. AU - Patel, U. D. AU - Powers, B. PY - 2011 DA - 2011// TI - AHRQ Comparative Effectiveness Reviews BT - Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update PB - Agency for Healthcare Research and Quality (US) CY - Rockville ID - Sanders2011 ER - TY - JOUR AU - Krum, H. AU - Massie, B. AU - Abraham, W. AU - Dickstein, K. AU - Køber, L. AU - McMurray, J. PY - 2011 DA - 2011// TI - Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren trial to minimize OutcomeS in patients with HEart failuRE (ATMOSPHERE) study JO - Eur J Heart Fail VL - 13 UR - https://doi.org/10.1093/eurjhf/hfq212 DO - 10.1093/eurjhf/hfq212 ID - Krum2011 ER - TY - JOUR AU - Williams, B. AU - Mancia, G. AU - Spiering, W. AU - Agabiti Rosei, E. AU - Azizi, M. AU - Burnier, M. PY - 2018 DA - 2018// TI - 2018 ESC/ESH guidelines for the management of arterial hypertension JO - Eur Heart J VL - 39 UR - https://doi.org/10.1093/eurheartj/ehy339 DO - 10.1093/eurheartj/ehy339 ID - Williams2018 ER -